Strategy definition, marketing plan, product positioning, segmentation & targeting, call plan, pricing, stakeholder engagement (eg KOL, patients), budget management, HCP communication
Over the course of my 10 years career within Pharmaceutical Marketing , I've had the opportunity either to launch innovative products and work with mature ones, accross different settings (Retail and Hospital) and covering different Targets and Therapeutic Areas (eg specialists - Gastro, Cardio, Respiratory - and pharmacists).
In 2018, I started my Corporate tasks as Business Advisor in the Chiesi Region Europe Team, where I was responsible for the commercial governance and strategy of Top5 EU countries, thus involved in pivotal processes such as Strategic Planning, Commercial Excellence and Budget-Forecast.
From mid 2020, I lead the Global Strategy & Execution of Chiesi Consumer Health Care, with the main goal to internationalize the French VMS company NHCO.
Thanks to the set of skills acquired during my experience, I have been recognized as a person with a strong ability to adapt to different environments, markets and cultures.
Leading the integration and the internationalization of the French VMS company NHCO after the acquisition by Chiesi Group.
Responsibility in the commercial governance of Top 5 EU (IT, FR, ES, UK, DE)
Leading the Muscle-Skeletal & Gastro portfolio (with Rx and VMS products) targeting Ortho and Gastro.
Line Ext project lead for Muscle-Skeletal VMS (Darfax & Kalanit).
Leading Pain & Respiratory portfolio (class A & OTC brands), targeting GPs, Ortho and Pharmacies.
Leading the re-launch of the brand Corlentor in the hospital & retail market, with the indications SCAD and Chronic Heart Failure, following the Therapeutic Plan removal.
Marketing activities (eg promotional materials, market research) on Vaccine Prevenar-13, targeting GPs and specialists.